Abstract
Prior to the discovery of Helicobacter pylori it was considered unlikely that bacterial pathogens could colonise the stomach due to the arid environment created by acid secretion and other defensive factors. Microbial infection of the gastric mucosa is prevented in part by the production of mucus and several proteins with antibacterial actions, such as lysozyme and lactoferrin, as well as structurally by the tight junctions at the apical border of the epithelial cells. H. pylori, cultured for the first time from human gastric mucosa in 1983 (1), not only colonises human gastric epithelium but is also currently considered as the major aetiological agent in the pathogenesis of chronic gastritis and peptic ulcer disease (2, 3). Development of gastric cancer (4, 5) and lymphoma (6, 7) have also been related to H. pylori colonisation. It is now generally accepted that H. pylori infection is acquired in childhood from other infected individuals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;i:1273–1275.
Marshall B, Warren J. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984:i:1311–1315.
Blaser M. Gastic Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology 1987;93:371–383.
Parsonnet J, Friedman G, Vandersteen D, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 1991;325:1170–1171.
Clarkson K, West K. Gastric cancer and Helicobacter pylori infection. J. Clin. Pathol. 1993;46:997–999.
Wotherspoon A, Ortiz-Hidalgo C, Falzon M, Issaacson P. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175–1176.
Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure ofHelicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995;345:1591–1594.
Marshall B, Barret L, Prakash C, McCallum R, Guerrant R. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology 1990;99:697–702.
Wyle F, Tarnawski A, Schulman D, Dabros W. Evidence for gastric mucosal cell invasion by C. pylori: an ultrastructural study. J. Clin. Gastroenterol. 1990;12 Suppl. I:S92–98.
Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm A. Local cytokine response in Helicobacter pylori-infected subjects. Infect. Immun. 1998;66:5964–5971.
Appelmelk B, Negrini R, Moran A, Kuipers E. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol. 1997;5:70–73.
Blanchard T, Czinn S, Nedrud J. Host response and vaccine development to Helicobacter pylori infection. Curr. Top. Microbiol. Immunol. 1999;241:181213.
Ilver D, Arngvist A, Ogren J, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998;16:373–377.
Smoot D, Resau J, Naab T, et al. Adherence of Helicobacter pylori to cultured human gastric epithelial cells. Infect. Immun. 1993;61:350–355.
Dytoc M, Gold B, Louie M. Comparison of H. pylori and attaching-effacing Escherichia coli adhesion to eukaryotic cells. Infect. Immun. 1992;61:448–456.
Terras A, Pajares J, Hopkins A, et al. Helicobacter pylori disrupts epithelial barrier function in a process inhibited by protein kinase C activators. Infect. Immun. 1998;66:2943–2950.
Goodwin C, Armstrong J, Marshal B. Campylobacter pyloridis, gastritis and peptic ulceration. J. Clin. Pathol. 1986;39:353–365.
Shimoyama T, Everett S, Dixon M, Axon A, Crabtree J. Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J. Clin. Pathol. 1998;51:765–770.
Yashumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. J. Biol. Chem. 1992;267:22506–22511.
Rieder G, Hatzi R, Walz A, Stolte M, Enders G. Differences in regulation of CXC-chemokines and IL-8 in Helicobacter pylori-associated gastritis. Immunology Letters 1999, 69 (Special issue, 10th International Congress of Mucosal Immunology Abstracts): 29.
Aihara M, Tsuchimoto D, Takizawa H, et al. Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line MKN45. Infect. Immun. 1997;65:3218–3224.
Crabtree J, Peich P, Wyatt J, Stachl U, Lindley I. Gastric interleukin-8 and IL-8 autoantibodies in H. pylori infection. Scand. J. Immunol. 1993;37:65–70.
Harris P, Ernst P, Kawabata S, Kiyono H, Graham M, Smith P. Recombinant Helicobacter pylori urease activates primary mucosal macrophages. J. Infect. Dis. 1998;178:1516–1520.
Yes G, Brousard R, Crowe S, Reyes V. Increased expression of interleukin 16 by gastric epithelium during Helicobacter pylori infection. Immunology Letters 1999;69:29 (Special issue, 10th International Congress of Mucosal Immunology Abstracts).
Sobala G, Crabtree J, Dixon M, et al. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut 1991;32:14151418.
Tricottet V, Bruneval P, Vire O, et al. Campylobacter-like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: an ultrastructural study. Ultrastruct. Pathol. 1986;10:113–122.
Alam K, Schubert T, Bologna S. Increased density of Helicobacter pylori on antral biopsy is associated with severity of acute and chronic inflammation and likelihood of duodenal ulceration. Am. J. Gastroenterol. 1992;87:424–428.
Khulusi S, Mendall M, Patel P, Levy J, Badve S, Northfield T. Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects. Gut 1995;37:319–324.
Rachmilewitz D, Karmeli F, Eliakim R, et al. Enhanced gastric nitric oxide synthase activity in duodenal ulcer patients. Gut 1994;35:1394–1397.
Modlin R, Nutman T. Type 2 cytokines and negative immune regulation in human infections. Curr. Opin. Immunol. 1993;5:511–517.
Di-Tommaso A, Xiang Z, Bugnili M, et al. Helicobacter pylori-specific CD4+ T-cell clones from peripheral blood and gastric biopsies. Infect. Immunol. 1995;63:1102–1106.
Clerici M, Shearer G. A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 1993;14:107–111.
Yamamura M, Wang X, Ohmen J, et al. Cytokine patterns of immunologically mediated tissue damage. J. Immunol. 1992;15:1470–1475.
Yamamura M, Uyemura K, Deans R, et al. Defining protective responses to pathogens: cytokine profiles in leprosy sesions. Science 1991;254:277–279.
DElios M, Manghetti M, Almerigogna F, et al. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur. J. Immunol. 1997;27:1751–175.
Fan X, Chua A, Shasi C, et al. Antigen-specific gastric lymphocyte responses to patients with gastric H. pylori infection and IFN-y production. Gastroenterology 1993;104 (Suppl): A698.
Fan X, Chua A, Shahi C, McDevitt J, Keeling P, Kelleher D. Gastric T lymphocyte responses to H. pylori in patients with H. pylori colonisation. Gut 1994;35:1379–1384.
Bodger K, Wyatt J, Heatley R. Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion. Gut 1997;40:739–744.
Hatz R, Meimarakis G, Bayerdorffer E, Stolte M, Kirchner T, Enders G. Characterization of lymphocytic infiltrates in Helicobacter-pylori associated gastritis. Scand. J. Gastroenterol. 1996;31:222–228.
Seifarth C, Deusch K, Reich K, Classen M. Local cellular immune response in Helicobacter pylori associated type B gastritis--selective increase of CD4+ but not gamma delta T-cells in the immune response to H. pylori antigens. Z. Gastroenterol. 1996;34:215–224.
Genta R, Hamner H, Graham D. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum. Pathol. 1993;24:577–583.
Sarsfield P, Jones D, Wotherspoon A, Harvard T, Wright D. A study of accessory cells in the acquired lymphoid tissue of Helicobacter gastritis. J. Pathol. 1996;180:18–25.
Terras A, Pajares J. An increased number of follicles containing activated CD69+ helper T cells and proliferating CD71+ B cells are found in H. pylori-infected gastric mucosa. Am. J. Gastroenterol. 1998;93:579–583.
Hussell T, Isaacson P, Crabtree J, Spencer J. The response of cells from low grade B cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993;342:571–574.
Eidt S, Stolte M, Fischer R. Helicobacter pylori gastritis and primary gastric non-Hodgkin¡¯s lymphoma. J. Clin. Pathol. 1994;47:436–439.
Nakamura S, Yao T, Aoyagi K, Lida M, Fujishima M, Tsuneyoshi M. Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer 1997;79:3–11.
Engstrand L, Scheynius A, Pahlson C. An increased number of gamma/delta T-cells and gastric epithelial cell expression of the groEL stress-protein homologue in Helicobacter pylori-associated chronic gastritis of the antrum. Am. J. Gastroenterol. 1991;86:976–980.
Ibraghimov A, Kabok Z, Garcia G, Castriotta L, Torrey D, Papo J. Development of gastric aĂŸ+ CD4+ intraepihtelial lymphocytes induced by Helicobacter pylori infection. Immunology Letters 1999;69:29.
Scheynius A, Engstrand L. Gastric epithelial cells in Helicobacter pylori-associated gastritis express HLA-DR but not ICAM-1. Scand. J. Immunol. 1991;33:237–241.
Bergquist C, Mattsson-Rydberg A, Edebo A, Svennerholm A. Antigen presenting cells in the stomach and duodenum of Helicobacter pylori infected and healthy individuals. Immunology Letters 1999;69:50.
Fan X, Crowe S, Behar S, et al. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type I-mediated damage. J. Exp. Med. 1998;18:1659–1669.
Hatz R, Rieder G, Stolte M, et al. Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis. Gastroenterology 1997;112:1908–1919.
Darveau R, Cunningham M, Bailey T, et al. Ability of bacteria associated with chronic inflammatory diesease to stimulate E-selectin expression and promote neutrophil adhesion. Infect. Immun. 1995;63:1311–1317.
Campanero M, Pulido R, Ursa M, Rodriguez-Moya M, LandĂ¡;;duri Md, S¨¢nchez-Madrid F. ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway. J. Cell. Biol. 1990;123:1007–1016.
Dougherty G, Hogg N. The role of monocyte lymphocyte function-associated antigen 1 (LFA-1) in accessory cell function. Eur. J. Immunol. 1987;17:943947.
Shaw S, Luce G, Quinones R, et al. Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones. Nature 1986;323:262–2 64.
Malegapuru W, Martin E, Gale E, et a. ICAM-1 a ligand for LFA-1 dependent adhesion of B, T and myeloid cells. Nature 1988;331:86–88.
Fan X, Long A, Fan S, Keeling P, Kelleher D. Adhesion molecule expression on gastric intraepithelial lymphocytes of patients with Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol. 1995;7:541–546.
Higuchi K, Arakawa T, Uchida T, et al. In situ expression of cell adhesion molecules in chronic gastritis with Helicobacter pylori infection. J. Clin. Gastroenterol. 1997;25 (Suppl 1):S215–221.
Enders G, Brooks W, Von-Jan N, Lehn N, Bayerdorffer E, Hatz R. Expression of adhesion molecules on human granulocytes after stimulation with Helicobacter pylori membrane proteins: comparison with membrane proteins from other bacteria. Infect. Immun. 1995;63:2473–2477.
Mackay C, Terpe H, Stauder R, al e. Expression and modulation of CD44 variant isoforms in humans. J. Cell. Biol. 1994;124:71–82.
Mayer B, Jauch K, Gunthert U, et al. De-novo expression of CD44 and survival in gastric cancer. Lancet 1993;342:1019–1022.
Fan X, Long A, Goggins M, Fan X, Keeling P Kelleher D. Expression of CD44 and its variants on gastric epithelial cells of patients with Helicobacter pylori colonisation. Gut 1996;38:507–512.
Fixa B, Komarkova O, Krejsek J, Nozicka Z, Bures J. Specific cellular immune response in patients with Helicobacter pylori infection. Hepatogastroenterology 1990;37:606–607.
Bak-Romaniszyn L, Malecka-Panas E, Zeman K, et al. Helicobacter pylori infection in the etiopathogenesis of duodenal ulcer in children. J. Physiol. Pharmacol. 1996;47:209–220.
Kelly F, Amstrong P, Bamford K. Effect of Helicobacter pylori on ICAM-1 expression and cytokine production on monocytes and endothelial cells. Immunology Letters 1999;69:51–52.
Negrini R, Lisato L, Zanella I, et al. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 1991;101:437–445.
Rietschel E, Brade H, Holst O, et al. Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immunol. 1996;216:39–81.
Aspinall G, Monteiro M, Pang H, Walsh E, Moran A. Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen chain and core oligosaccharide regions. Biochemistry 1996;35:24892497.
Appelmelk B, Simoons-Smith, Negrini R, et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect. Immun. 1996, 64: 2031–2040.
Wirth I-I, Yang M, Jr RP, Tham K, Blaser M. Helicobacter pylori Lewis expression is related to the host Lewis phenotype. Gastroenterology 1997;113:1091–1098.
Monteiro M, Chan K, Rasko D, et al. Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between H. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. J. Biol. Chem. 1998;273:11533–11543.
Birkholz S, Knipp U, Nietzki C, Adamek R, Opferkuch W. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria. FEMS Immunol. Med. Microbiol. 1993;6:317–324.
Moran A. The role of lipopoysaccharide in Helicobacter pylori pathogenesis. Aliment. Pharmacol. Ther. 1996;10 (Suppl 1):39–50.
Toh B, van-Driel I, Gleeson P. Autoimmune gastritis: tolerance and autoimmunity to the gastric H+/K+ ATPase (proton pump). Autoimmunity 1992;13:165–172.
Claeys D, Faller G, Appelmelk B, Negrini R, Kirchner T. The gastric H},K+ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 1998;115:340–347.
Faller G, Winter M, Steininger H, et al. Decrease of antigastric autoantibodies in Helicobacter pylori gastritis after cure of infection. Pathol. Res. Pract. 1999;195:243–246.
Vorobjova T, Faller G, Maaroos H, Kirchner H, Villako K, Uibo R. Anticanalicular autoantibodies in an adult sample with high seroprevalence of Helicobacter pylori: a follow up study. Immunology Letters 1999;69:49.
Boren T, Falk P, Roth K, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993;262:1892–1895.
Rathbone B, Wyatt J. Systemic and local antibody responses to gastric Campylobacter pyloridis in nonulcer dyspepsia. Gut 1986;27:642–647.
Crabtree J, Shallcross T, Wyatt J, et al. Mucosal humoral immune response to Helicobacter pylori in patients with duodenitis. Dig. Dis. Sci. 1991;36:12661273.
Shimoyama T, Crabtree J. Bacterial factros and immune pathogenesis in Helicobacter pylori infection. Gut 1998;43 (Suppl 1): S2–S5.
Bontkes H, Veenendaal R, Pena A, et al. IgG subclass response to Helicobacter pylori in patients with chronic active gastritis and duodenal ulcer. Scand. J. Gastroenterol. 1992;27:129–33.
Andersen L, Gaarslev K. IgG subclass antibodies against Helicobacter pylori heat-stable antigens in normal persons and in dyspeptic patients. APMIS 1992;100:747–751.
Kreuning J, Lindeman J, Biemond I, Lamers C. Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects. J. Clin. Pathol. 1994;47:227–231.
Watanabe T, Goto H, Arisawa T, et al. Relationship between local immune response to Helicobacter pylori and the diversity of disease: investigation of H. pylori-specific IgA in gastric juice. J. Gastroenterol. Hepatol. 1997;12:660–665.
Futagami S, Takahashi H, Norose Y, Kobayashi M. Systemic and local immune responses against Helicobacter pylori urease in patients. Gut 1998;43:168–175.
Cutler A, Prasad V. Long-term follow-up of Helicobacter pylori serology after successful eradication. Am. J. Gastroenterol. 1996;91:85–88.
Lerang F, Haug J, Mourn B, et al. Accuracy of IgG serology and other test in confirming Helicobacter pylori eradication. Scand. J. Gastroenterol. 1998;33:710–715.
Sugiyama T, Awakawa T, Hayashi S, et al. The effect of the immune response to Helicobacter pylori in the development of intestinal metaplasia. Eur. J. Gastroenterol. Hepatol. 1994;6 (Suppl 1): S89–92.
Xiang Z, Cemsini S, Bayeli P, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinicals isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect. Immun. 1995;63:94–98.
Wyatt J, Rathbone B, Heatley R. Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J. Clin. Pathol. 1986;39:863–870.
Kazi J, Sinniah R, Jaffrey N, et al. Cellular and humoral immune responses in Campylobacter pylori-associated chronic gastritis. J. Pathol. 1989;159:231–237.
Darwin P, Zheng MSQ, James S, Fantry G. Immune evasion by Helicobacter pylori: gastric spiral bacteria lack surface immunoglobulin deposition and reactivity with homologous antibodies. Helicobacter 1996;1:20–27.
Birkholz S, Schneider T, Knipp U, Stallmach A, Zeitz M. Decreased Helicobacter pylori-specific gastric secretory IgA antibodies in infected patients. Digestion 1998;59:638–645.
Windle H, Nà Eidhin D, Kelleher D. The thioredoxin system of Helicobacter pylori: a role for redox activity in pathogenesis? Immunology Letters 1999;69:49–50.
Schutze K, Hentsche E, Dragosict B, Hirschl A. Helicobacter pylori reinfection with identical organisms: transmission by the patients’ spouses. Gut 1995;36:831–833.
Walker R. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 1994;12:387–400.
Czinn S, Nedrud J. Oral immunization against Helicobacter pylori. Infect. Immun. 1991;59:2359–2363.
Chen M, Lee A, Hazell S. Immunisation against gastric Helicobacter infection in a mouse/Helicobacter felis model. Lancet 1992;339:1120–1121.
Ferrero R, Thiberge J, Huerre M, Labigne A. Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection. Infect. Immun. 1994;62:4981–4989.
Ferrero R, Thiberge J, Kansau I, Wuscher N, Huerre M, Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc. Natl. Acad. Sci. U S A 1995;92:6499–6503.
Marchetti M, Rossi M, Giannelli V, et al. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxin mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine 1998;16:33–37.
Myers G, Ermak T, Georgakopoulos K, et al. Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection. Vaccine 1999;17:1394–1403.
Kim S, Doh H, Jong M, Ha Y, Chung S, Park H. Oral immunization with Helicobacter pylori-loaded poly-(D,L-Lactide-co-glycolide) nanoparticles. Helicobacter 1999;4:33–39.
Kim S, Doh H, Ahn J, et al. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,Llactide-co-glyucolide) microparticles. Vaccine 1999;17:238–243.
Michetti P, Dorta G, Wiesel P, et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) Lal on Helicobacter pylori infection in humans. Digestion 1999;60:203–209.
Campbell M, Tran C, Johnson R, Butler R, Davidson G. Hyperimmune bovine colostrum: protection of mice against Helicobacter pylori infection. Immunology Letters 1999;69:65–72.
Gomez-Duarte O, Bumann D, Meyer T. The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases. Vaccine 1999;17:1667–1673.
Weltzin R, Klenthous H, Guirakhoo F, Monath T, Lee C. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection. Vaccine 1997;15:370–376.
Kleanthous H, Myers G, Georgakopoulos K, et al. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect. Immun. 1998;66:2879–2886.
Guy B, Hessler C, Fourage S, et al. Systemic immunization with urease protects mice against Helicobacter pylori infection. Vaccine 1998;16:850–856.
Guy B, Hessler C, Fourage S, Rokbi B, Millet M. Comparison between targeted and untargeted systemic immunizations with adjuvanted urease to cure Helicobacter pylori infection in mice. Vaccine 1999;5:370–376.
Nedrud J, Blanchard T, Gottwein J,et al. Systemic vaccination inducing either Th 1 or Th2 immunity protects mice from challenge with H. pylori. Immunology Letters 1999;69:52.
Michetti P, Kreiss C, Kotloff K, et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 1999;116:804–812.
Dubois A, Lee C, Fiala N, Kleanthous H, Mehlman P, Monath T. Immunization against natural Helicobacter pylori infection in nonhuman primates. Infect. Immun. 1998;66:4340–4346.
Lee C, Soike K, Hill J, et al. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. Vaccine 1999;17:1493–1505.
Michetti P, Corthesy-Theulaz I, Davin C, et al. Immunization of BALB/c mice against Helicobacter fees infection with Helicobacter pylori urease. Gastroenterology 1994;107:1002–1011.
Lee C, Weltzin R, Thomas WD Jr., et al. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J. Infec. Dis. 1995;172:161–172.
Radcliff F, Hazell S, Kolesnikow T, Doidge C, Lee A. Catalase, a novel antigen for Helicobacter pylori vaccination. Infect. Immun. 1997;65:4668–4674.
Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995;267:1655–1658.
Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn S. Murine CD4 T-cell response to Helicobacter infection: Th-1 cells enhance gastritis and cells reduce bacterial load. Gastroenterology 1997;113:1848–1857.
Blandchard T, Czinn S, Redline R, Sigmund N, Harriman G, Nedrud J. Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice. Cell. Immunol. 1999;10:74–80.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Kluwer Academic Publishers
About this chapter
Cite this chapter
Windle, H.J., Terrés, A.M., Kelleher, D. (2001). Immunological aspects of Helicobacter pylori infection. In: Mahida, Y.R. (eds) Immunological Aspects of Gastroenterology. Immunology and Medicine Series, vol 31. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0790-0_7
Download citation
DOI: https://doi.org/10.1007/978-94-010-0790-0_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-3852-2
Online ISBN: 978-94-010-0790-0
eBook Packages: Springer Book Archive